SARS-CoV-2 protein microarray analysis is essential for assessing immunity at a population level. The findings highlight the need for adjusted vaccination strategies and ongoing surveillance of humoral immunity to address emerging SARS-CoV-2 variants effectively.
Hsu et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: